FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078393821> ?p ?o ?g. }

• W2078393821 endingPage "728" @default.
• W2078393821 startingPage "725" @default.
• W2078393821 abstract "Back to table of contents Previous article Next article Brief ReportFull AccessEnd-of-Life Care for Veterans With Schizophrenia and CancerLinda Ganzini M.D., M.P.H.Robert Socherman Ph.D.Jonathan Duckart M.P.S.Molly Shores M.D.Linda Ganzini M.D., M.P.H.Search for more papers by this authorRobert Socherman Ph.D.Search for more papers by this authorJonathan Duckart M.P.S.Search for more papers by this authorMolly Shores M.D.Search for more papers by this authorPublished Online:1 Jul 2010https://doi.org/10.1176/ps.2010.61.7.725AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail The goals of palliative care are relief of suffering and improvement in quality of life for patients facing life-threatening illness. Such improvements are made through prevention, assessment, and treatment of pain and other symptoms and the provision of psychological, emotional, and spiritual support ( 1 ). Palliative care is patient and family centered and emphasizes patient autonomy and advance planning for care. By 2003, 25% of U.S. hospitals sponsored a palliative care program ( 2 ). Patients become eligible for palliative care delivered by a hospice organization at the point they are expected to have less than six months of remaining life. The primary goals of hospice care are comfort and preservation of quality of life; cure of the terminal illness is no longer being pursued. Hospice care is delivered by an interdisciplinary cadre of physicians, nurses, social workers, and chaplains. Most often care is in patients' homes, but it also occurs in long-term care settings and, rarely, in inpatient hospice units. Although originally developed as an approach for patients with advanced cancer, currently over half of hospice enrollees in the United States have noncancer diagnoses. In 2007, 39% of all decedents in the United States were hospice enrolled before death ( 3 ). Hospice and palliative care are intuitively appealing for patients with both advanced cancer and chronic mental illnesses, such as schizophrenia. Little is known, however, about access, special needs, and barriers to palliative care for persons with chronic mental illness. End-of-life care is optimized when patients and their families participate in determining goals of care, yet half of patients with schizophrenia have impairments in decision-making capacity and when incapacitated, frequently lack surrogate decision makers ( 4 , 5 ). Home hospice requires the presence of a caregiver, most often a family member ( 3 ). Provision of palliative and hospice care can also be impeded by symptoms of schizophrenia, which impair development of a therapeutic alliance with medical providers, undermine motivation for advance care planning, and hinder communication about symptoms, including pain. Case reports document that some patients with schizophrenia do not acknowledge their cancer even when the malignancy reaches an advanced stage ( 4 , 6 ). If palliative goals of care are not explicitly communicated, patients may follow an antipalliative course, including terminal hospitalization and aggressive life-sustaining treatments, such as cardiopulmonary resuscitation (CPR). We theorized that patients with schizophrenia and cancer may suffer disparities in end-of-life care because, in addition to the aforementioned potential barriers, there are disparities in their care at other stages of cancer treatment. For example, they are less likely to undergo preventive screenings for cervical, breast, prostate, and colorectal cancer, and several studies point to higher case fatality rates among patients with schizophrenia when cancer develops ( 7 , 8 ). The goal of this study was to compare measures of quality of end-of-life care among veterans with and without schizophrenia who died of cancer. We hypothesized that veterans with schizophrenia and advanced cancer, compared with those without major mental illness, would be less likely to complete advance directives, less likely to be enrolled in hospice, less likely to receive opioid medications before hospice enrollment, and more likely to die in the hospital without an order limiting CPR. Methods We used data from the data management system (DMS) of the U.S. Department of Veterans Affairs (VA) Northwest Health Network-Veterans Integrated Service Network (VISN) 20 (Oregon, Washington, and Alaska) to examine how cancer patients with schizophrenia are treated compared with cancer patients with no major mental illness. The DMS is a VISN-wide data repository that contains clinical information from each VA medical center (VAMC) in the northwestern United States, including demographic information, date of death, treatment dates, ICD-9 diagnoses, clinic appointments, and medications. We included veterans who died of cancer between January 1, 2003 (the date by which all VAMCs were required to have developed a palliative care team and to pay for hospice care for all veterans), and December 31, 2008. The study was approved as exempt from the need for written informed consent by the Portland VAMC Institutional Review Board. Veterans were classified as eligible cases for study inclusion if they had an ICD-9 diagnosis of schizophrenia or schizoaffective disorder, had attended at least one mental health clinic outpatient appointment, and were prescribed an antipsychotic. A research psychologist (RS), manually reviewed the medical records to confirm the accuracy of the psychiatric diagnosis and cancer as a cause of death. The comparison group was randomly selected from approximately 14,000 veterans who died with cancer in VISN 20 during the same period but who had not been diagnosed as having a major mental illness (any psychotic disorder or bipolar disorder). Information obtained from the DMS and from medical record review included demographic characteristics (age, sex, sites of care and death, and date of death), enrollment in and length of hospice care, prescription of any opioids in the last six months of life but before hospice enrollment, and presence of an advance directive or physician orders for life-sustaining treatment (POLST). The POLST is a set of regionally developed, portable, medical orders based on a patient's values for life-sustaining treatment ( 9 ). The orders stay with the patient regardless of care setting and are most often used to limit life-sustaining treatments, artificially delivered nutrition, and even transport to the hospital. We also determined whether the patient's cancer was biopsy proven and whether the patient's cancer was treated with surgery or chemotherapy. The groups were compared by Student's t test for continuous variables and chi square test for categorical variables with SPSS, version 17.0. All tests were two-tailed, and alpha was set at .05.Results Sixty patients with schizophrenia or schizoaffective disorder who died of cancer were identified and compared with 196 cancer decedents without major mental illness. As expected with an older veteran population, the cohort was overwhelmingly male ( Table 11 ). Patients with schizophrenia who died of cancer were, on average, six years younger than patients in the control group and were significantly less likely to have ever been married. Race and ethnicity data are often missing in this database, and therefore this information was not collected. Table 1 Characteristics of deceased veterans with cancer who did or did not have schizophreniaTable 1 Characteristics of deceased veterans with cancer who did or did not have schizophreniaEnlarge tableNone of our hypotheses predicting poorer-quality end-of-life care for patients with schizophrenia were substantiated. Fifty-eight percent of patients with schizophrenia had an advance directive, 73% were prescribed an opioid before hospice enrollment, and 63% had a physician order to forgo CPR. Only 27% of patients with schizophrenia died in the hospital, and over half (55%) were hospice enrolled. There were no differences between patients with schizophrenia and the comparison group on any of these measures. Some measures suggested that patients with schizophrenia had better end-of-life care than those without mental illness. They had longer hospice stays and were more likely to have a POLST documented. Patients with schizophrenia did not differ from the comparison group in the percentage who had biopsies or surgery for cancer, but they were significantly less likely to initiate chemotherapy (28% versus 43%, p=.04).DiscussionWe conducted a six-year, retrospective review of end-of-life care among veterans with cancer in the Northwest region of the United States. The main finding was that patients with schizophrenia received comparable or, on some measures, better end-of-life care than cancer patients without mental illness. In contrast, most studies indicate that patients with serious mental illness experience disparities in levels of cancer prevention and treatment.A strength of our study is its breadth—it captured data from seven medical centers, including data for all veterans receiving active care in Oregon, Washington, and Alaska. A weakness is that we may not have had access to records from civilian hospitals, particularly for veterans without mental illness. We also may have excluded patients with schizophrenia who were transient, not adherent to their treatment, or not well integrated into the care system. Patients with schizophrenia were significantly younger than patients without mental illness. Finally, we might have demonstrated statistically significant differences with a larger sample. Many case reports and commentaries outline the difficulties in caring for patients with schizophrenia and cancer, including patients' denial of having either disease, failure to seek care until cancer is advanced, uncooperativeness with and intolerance of cancer treatment, homelessness, and lack of family support ( 4 , 6 ). Foti and colleagues ( 10 , 11 ), in a study of 150 patients with serious mental illness, reported that most patients reported little experience with advance care planning, and yet when such planning was explained to them they were interested in participating, comfortable with the discussion, and understood the questions. Many expressed a preference for comfort care in scenarios of advanced disease. On the other hand, the study interviewers were often not comfortable discussing this topic with patients with major mental illness. Several factors may account for our findings. Within the VA there are fewer financial and insurance barriers to obtaining care. Between 2003 and 2004, the VA mandated that all VAMCs develop palliative care teams and assume financial responsibility for providing hospice care for all eligible patients ( 12 , 13 ). VA regulations allow a variety of interested parties to serve as surrogates for patients who lack decision-making capacity ( 14 ). These provisions may help to limit aggressive and inappropriate life-sustaining treatment such as CPR for unbefriended cancer patients. Finally, schizophrenia patients may not tolerate arduous life-prolonging treatments, such as chemotherapy, and may lack family support necessary for some cancer treatments. These patients may default earlier to less demanding comfort care, thus allowing longer hospice stays. ConclusionsOur data indicate that characteristics of schizophrenia patients that might predict poor end-of-life care—impaired decision-making capacity, homelessness, poor social support, noncompliance with treatments, difficulty communicating symptoms, and more frequent denial of illness—do not undermine appropriate care in the context of institutional processes that support hospice and palliative care.Acknowledgments and disclosuresThis study was supported in part by the VA Health Services Research and Development Research Enhancement Award Program, Portland, Oregon. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the VA or the U.S. government.The authors report no competing interests.Dr. Ganzini is affiliated with the Mental Health Division, Portland Veterans Affairs Medical Center (VAMC), R&D 66, P.O. Box 1034, Portland, OR 97207 (e-mail: [email protected]). Dr. Socherman and Mr. Duckart are with the Research Service at the Portland VAMC. Dr. Shores is with the Geriatric Research Education and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington.References1. WHO Definition of Palliative Care. Geneva, World Health Organization, Available at www.who.int/cancer/palliative/definition/en Google Scholar2. Morrison RS, Maroney-Galin C, Kralovec PD, et al: The growth of palliative care programs in United States hospitals. Journal of Palliative Medicine 8:1127–1134, 2005Google Scholar3. NHPCO Facts and Figures: Hospice Care in America. Alexandria, Va, National Hospice and Palliative Care Organization, Oct 2008Google Scholar4. Ganzini L, Socherman R: Cancer care for patients with schizophrenia; in Psycho-Oncology. Edited by Holland JC, Breibart WS, Jacobsen PB, et al. New York, Oxford University Press, 2010Google Scholar5. Foti ME: Do it your way: a demonstration project on end-of-life care for persons with serious mental illness. Journal of Palliative Medicine 6:661–669, 2003Google Scholar6. Irvin TL: Legal, ethical and clinical implications of prescribing involuntary life-threatening treatment: the case of the Sunshine Kid. Journal of Forensic Science 48:856–860, 2003Google Scholar7. Druss BG, Rosenheck RA, Desai MM, et al: Quality of preventive medical care for patients with mental disorders. Medical Care 40:129–136, 2002Google Scholar8. Lawrence D, Holman CD, Jablensky AV, et al: Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates. Acta Psychiatrica Scandinavica 101:382–388, 2000Google Scholar9. Center for Ethics in Health Care: Physician Orders for Life-Sustaining Treatment (POLST) Paradigm. Portland, Oregon Health and Science University, 2008. Available at www.ohsu.edu/polst Google Scholar10. Foti ME, Bartels SJ, Merriman MP, et al: Medical advance care planning for persons with serious mental illness. Psychiatric Services 56:576–584, 2005Google Scholar11. Foti ME, Bartels SJ, Van Citters AD, et al: End-of-life treatment preferences of persons with serious mental illness. Psychiatric Services 56:585–591, 2005Google Scholar12. VHA Directive 2003-008: Palliative Care Consult Teams (PCCT). Washington, DC, US Department of Veterans Affairs, Veterans Health Administration, Feb 4, 2003Google Scholar13. Community hospice care: referral and purchase procedures; in VHA Handbook, section 1140.5. Washington, DC, US Department of Veterans Affairs, Veterans Health Administration, Mar 1, 2005. Available at www1.va.gov/vhapublications/ViewPublication.asp?pub_ID=1229 Google Scholar14. Informed consent for clinical treatments and procedures; in VHA Handbook, section 1004.01. Washington, DC, US Department of Veterans Affairs, Veterans Health Administration, Aug 14, 2009. Available at www1.va.gov/vhapublications/ViewPublication.asp?pub_ID=2055 Google Scholar FiguresReferencesCited byDetailsCited byPsychiatric Comorbidities and Outcomes in Palliative and End-of-Life Care: A Systematic ReviewJournal of Pain and Symptom Management, Vol. 66, No. 1NDIS Participants with Psychosocial Disabilities and Life-Limiting Diagnoses: A Scoping Review16 August 2022 | International Journal of Environmental Research and Public Health, Vol. 19, No. 16End-of-life care for people with severe mental illness: the MENLOC evidence synthesis1 March 2022 | Health and Social Care Delivery Research, Vol. 10, No. 4Help Me Understand: Providing Palliative Care to Individuals With Serious Mental Illness20 April 2021 | American Journal of Hospice and Palliative Medicine®, Vol. 39, No. 2Palliative and high-intensity end-of-life care in schizophrenia patients with lung cancer: results from a French national population-based study2 September 2020 | European Archives of Psychiatry and Clinical Neuroscience, Vol. 271, No. 8Cancer and severe mental illness in low‐ and middle‐income countries: The challenges and outlook for the future27 August 2021 | Psycho-Oncology, Vol. 30, No. 12End of life care for people with severe mental illness: Mixed methods systematic review and thematic synthesis (the MENLOC study)3 September 2021 | Palliative Medicine, Vol. 18End-of-life care in schizophrenia: a systematic review19 June 2020 | International Psychogeriatrics, Vol. 33, No. 2End-of-Life Care in Individuals With Serious Mental IllnessPsychosomatics, Vol. 61, No. 5End-of-life care and place of death in adults with serious mental illness: A systematic review and narrative synthesis14 October 2019 | Palliative Medicine, Vol. 34, No. 1End-of-life care among patients with schizophrenia and cancer: a population-based cohort study from the French national hospital databaseThe Lancet Public Health, Vol. 4, No. 11Palliative and Supportive Care, Vol. 17, No. 04On the Margins of Death: A Scoping Review on Palliative Care and Schizophrenia10 October 2018 | Journal of Palliative Care, Vol. 34, No. 1Schizophrenia Research, Vol. 195PLOS ONE, Vol. 13, No. 11General Hospital Psychiatry, Vol. 44Cancer screening, prevention, and treatment in people with mental illness10 December 2015 | CA: A Cancer Journal for Clinicians, Vol. 66, No. 2“No Right Place to Die”29 February 2016 | Journal of the American Psychiatric Nurses Association, Vol. 22, No. 1Collegian, Vol. 22, No. 1Retrospective studies of end-of-life resource utilization and costs in cancer care using health administrative data: A systematic review27 May 2014 | Palliative Medicine, Vol. 28, No. 10Cancer, Vol. 120, No. 3Schizophrenia Research, Vol. 141, No. 2-3 Volume 61Issue 7 July, 2010Pages 725-728PSYCHIATRIC SERVICES July 2010 Volume 61 Number 7 Metrics PDF download History Published online 1 July 2010 Published in print 1 July 2010" @default.
• W2078393821 created "2016-06-24" @default.
• W2078393821 creator A5007231351 @default.
• W2078393821 creator A5041384032 @default.
• W2078393821 creator A5050102042 @default.
• W2078393821 creator A5063009515 @default.
• W2078393821 date "2010-07-01" @default.
• W2078393821 modified "2023-10-04" @default.
• W2078393821 title "End-of-Life Care for Veterans With Schizophrenia and Cancer" @default.
• W2078393821 cites W1962783348 @default.
• W2078393821 cites W1984161682 @default.
• W2078393821 cites W1986898046 @default.
• W2078393821 cites W2017359630 @default.
• W2078393821 cites W2073947948 @default.
• W2078393821 cites W2137975390 @default.
• W2078393821 cites W2147373731 @default.
• W2078393821 cites W2410396384 @default.
• W2078393821 doi "https://doi.org/10.1176/ps.2010.61.7.725" @default.
• W2078393821 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20592010" @default.
• W2078393821 hasPublicationYear "2010" @default.
• W2078393821 type Work @default.
• W2078393821 sameAs 2078393821 @default.
• W2078393821 citedByCount "24" @default.
• W2078393821 countsByYear W20783938212012 @default.
• W2078393821 countsByYear W20783938212013 @default.
• W2078393821 countsByYear W20783938212014 @default.
• W2078393821 countsByYear W20783938212015 @default.
• W2078393821 countsByYear W20783938212016 @default.
• W2078393821 countsByYear W20783938212017 @default.
• W2078393821 countsByYear W20783938212018 @default.
• W2078393821 countsByYear W20783938212019 @default.
• W2078393821 countsByYear W20783938212020 @default.
• W2078393821 countsByYear W20783938212021 @default.
• W2078393821 countsByYear W20783938212022 @default.
• W2078393821 countsByYear W20783938212023 @default.
• W2078393821 crossrefType "journal-article" @default.
• W2078393821 hasAuthorship W2078393821A5007231351 @default.
• W2078393821 hasAuthorship W2078393821A5041384032 @default.
• W2078393821 hasAuthorship W2078393821A5050102042 @default.
• W2078393821 hasAuthorship W2078393821A5063009515 @default.
• W2078393821 hasConcept C118552586 @default.
• W2078393821 hasConcept C121608353 @default.
• W2078393821 hasConcept C126322002 @default.
• W2078393821 hasConcept C15744967 @default.
• W2078393821 hasConcept C2776412080 @default.
• W2078393821 hasConcept C71924100 @default.
• W2078393821 hasConcept C74909509 @default.
• W2078393821 hasConceptScore W2078393821C118552586 @default.
• W2078393821 hasConceptScore W2078393821C121608353 @default.
• W2078393821 hasConceptScore W2078393821C126322002 @default.
• W2078393821 hasConceptScore W2078393821C15744967 @default.
• W2078393821 hasConceptScore W2078393821C2776412080 @default.
• W2078393821 hasConceptScore W2078393821C71924100 @default.
• W2078393821 hasConceptScore W2078393821C74909509 @default.
• W2078393821 hasIssue "7" @default.
• W2078393821 hasLocation W20783938211 @default.
• W2078393821 hasLocation W20783938212 @default.
• W2078393821 hasOpenAccess W2078393821 @default.
• W2078393821 hasPrimaryLocation W20783938211 @default.
• W2078393821 hasRelatedWork W2081026367 @default.
• W2078393821 hasRelatedWork W2129691177 @default.
• W2078393821 hasRelatedWork W2337455227 @default.
• W2078393821 hasRelatedWork W2395652175 @default.
• W2078393821 hasRelatedWork W2612097706 @default.
• W2078393821 hasRelatedWork W2618232408 @default.
• W2078393821 hasRelatedWork W2748952813 @default.
• W2078393821 hasRelatedWork W2899084033 @default.
• W2078393821 hasRelatedWork W2973388722 @default.
• W2078393821 hasRelatedWork W4211108626 @default.
• W2078393821 hasVolume "61" @default.
• W2078393821 isParatext "false" @default.
• W2078393821 isRetracted "false" @default.
• W2078393821 magId "2078393821" @default.
• W2078393821 workType "article" @default.